It is well recognized among medical professions that a patient-centered multidisciplinary collaboration in pharmacotherapy is important to maximize the efficacy of drug therapy and minimize the adverse drug reactions. It is true especially for cancer chemotherapy because anticancer drugs have severe side effects and its management may affect the outcome of treatment. In this symposium, I will introduce our collaborative approach in cancer chemotherapy for outpatients currently implemented at Nagoya University Hospital, and discuss the future direction.